Partnerships are key for rare disease drug discovery and development

What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of the leading global rare disease patient advocacy organization, and the impact patient advocacy groups are making on rare disease research.

Interviewer: Erin Righetti – Senior Manager, Content Marketing and Communications, EBD Group
Interviewee: Wendy White – Chair, Global Genes